Articles
Page 3 of 82
-
Citation: Orphanet Journal of Rare Diseases 2011 6:6
-
Pluripotent stem cells for pathological modelling of Hutchinson-Gilford Progeria Syndrome (HGPS) and drug discovery
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 2):O2 -
Characterization of conformation-specific, human-derived monoclonal antibodies against TTR aggregates with potential for diagnostic and therapeutic use
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P39 -
Comparison of MIBG and Diphosphonate scintigraphy in cardiac involvement of aTTR-FAP
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P43 -
The Swedish rare disease information database and the Swedish information centre for rare diseases
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):O27 -
Cross-border health care represents a key issue in the field of rare diseases
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):O31 -
Leveraging existing opportunities for improved Orphan Drug approval in the EU
Citation: Orphanet Journal of Rare Diseases 2012 7(Suppl 2):A27 -
European Reference Networks: developing a EUCERD opinion
Citation: Orphanet Journal of Rare Diseases 2012 7(Suppl 2):A6 -
Correction: Multivariate analysis and model building for classifying patients in the peroxisomal disorders X-linked adrenoleukodystrophy and Zellweger syndrome in Chinese pediatric patients
Citation: Orphanet Journal of Rare Diseases 2023 18:150 -
Correction to: Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia
Citation: Orphanet Journal of Rare Diseases 2022 17:143 -
A phase 3 clinical trial with ISIS-TTRRx, a 2nd-generation antisense oligonucleotide targeting transthyretin (TTR), for the treatment of TTR amyloid cardiomyopathy
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P8 -
Correction: Expert opinion of an Italian working group on the assessment of cognitive, psychological, and neurological outcomes in pediatric, adolescent, and adult patients with phenylketonuria
Citation: Orphanet Journal of Rare Diseases 2023 18:44 -
TUDCA as an autophagic modulator of ATTR V30M Amyloidosis
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P10 -
TTR-FAP: liver transplant vs oral medication. How and when
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I6 -
European Network of Rare Disease Help Lines (ENRDHLs) – caller profile analysis 2013
Citation: Orphanet Journal of Rare Diseases 2014 9(Suppl 1):O13 -
The impact of a small parental network: how 11q improved research, knowledge, contacts and support
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):O8 -
European Project for Rare Diseases National Plans Development (EUROPLAN)
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):P2 -
3D culture system of muscle precursor cell to reveal mechanosensing defects in nuclear envelope related disorders
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 2):O4 -
Coexistence of degenerative aortic stenosis and wild type transthyretin-related cardiac amyloidosis: a potentially dangerous association that can be non-invasively identified
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P45 -
Cross-border healthcare? The Polish experience
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):O29 -
The political empowerment of rare disease patient advocates both at EU and national level
Citation: Orphanet Journal of Rare Diseases 2012 7(Suppl 2):A33 -
Correction to: Sharing is caring: a call for a new era of rare disease research and development
Citation: Orphanet Journal of Rare Diseases 2023 18:15 -
Impairment of Lamin A/C-Polycomb crosstalk as a possible epigenetic cause of Emery Dreifuss Muscular Dystrophy (EDMD)
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 2):O10 -
Early intervention with tafamidis provides long-term benefit in delaying neurological progression in patients with transthyretin familial amyloid polyneuropathy
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P12 -
ATTR-FAP: liver transplantation vs oral medication, how and when
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I8 -
Emergency guidelines and emergency cards
Citation: Orphanet Journal of Rare Diseases 2014 9(Suppl 1):O15 -
Genetic testing in Europe: transborder testing is a necessity
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):P4 -
Hypothalamic involvement in premature aging laminopathies
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 2):O6 -
Quantitative comparison between amyloid deposition detected by 99mTc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin related cardiac amyloidosis
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P47 -
Spotting senile systemic amyloidosis: why we miss it
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P51 -
The democratic problem in the knowledge society of today: Rare Disorders Denmark’s documentation strategy
Citation: Orphanet Journal of Rare Diseases 2012 7(Suppl 2):A35 -
Primary Immunodeficiencies (PID): driving diagnosis for optimal care in Europe
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):P10 -
Chromatin dynamics and in vitro biomarkers in laminopathies: an overview
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 2):O12 -
Reimbursement of orphan drugs: the Pompe and Fabry case in the Netherlands
Citation: Orphanet Journal of Rare Diseases 2014 9(Suppl 1):O17 -
Health care cost-containment measures in the context of the economic crisis: impact analysis
Citation: Orphanet Journal of Rare Diseases 2014 9(Suppl 1):O21 -
Cystic Fibrosis in Europe - remote measurement of outcome
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):P6 -
Analysis of disease progression in patients with transthyretin cardiac amyloidosis
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O10 -
New therapeutic approaches to HGPS based on progerin inhibition
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 2):O8 -
Usefulness of 99mTc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P49 -
Correction to: A complex pheotype in a girl with a novel heterozygous missense variant (p.Ile56Phe) of the GNAS gene
Citation: Orphanet Journal of Rare Diseases 2022 17:169 -
Developing a cure for Black Bone Disease
Citation: Orphanet Journal of Rare Diseases 2012 7(Suppl 2):A37 -
First German Academy for Further Medical Training on Rare Diseases (FAKSE,http://www.fakse.info)
Citation: Orphanet Journal of Rare Diseases 2012 7(Suppl 2):A41 -
Registry of Outcome Measures (ROM); tools supporting review and selection of outcome measures (OMs) for studies and trials
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):P12 -
Correction to: Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to “TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases”)
Citation: Orphanet Journal of Rare Diseases 2021 16:320 -
Correction to: Comprehensive genetic characteristics of dystrophinopathies in China
An amendment to this paper has been published and can be accessed via the original article.
Citation: Orphanet Journal of Rare Diseases 2021 16:252 -
Altered cytokine profiles in laminopathic patients
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 2):O14 -
Familial amyloidotic polyneuropathy associated with the transthyretin CYS 114 gene in a Russian pair of monozygotic twins.
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P16 -
FAP in India: a first genetically proven case
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P20 -
Findacure – the Fundamental Diseases Partnership
Citation: Orphanet Journal of Rare Diseases 2014 9(Suppl 1):O23 -
Cell therapies for Duchenne muscular dystrophy: some ethical issues for personalised medicines
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):P8
Follow
- ISSN: 1750-1172 (electronic)